Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07206706) titled 'Efficacy and Tolerability of Tadalafil Versus Darifenacin in Management of Ureteric Stent-Related LUTS: Results From a Randomized Crossover Trial' on Sept. 26.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Ain Shams University
Condition:
Management of Ureteric Stent Related LUTS and Pain
Intervention:
Drug: Tadalafil 5Mg Tab
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: May 1, 2022
Target Sample Size: 150
Countries of Recruitment:...